Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts' Criteria

Carlo Catassi, Luca Elli, Bruno Bonaz, Gerd Bouma, Antonio Carroccio, Gemma Castillejo, Christophe Cellier, Fernanda Cristofori, Laura de Magistris, Jernej Dolinsek, Walburga Dieterich, Ruggiero Francavilla, Marios Hadjivassiliou, Wolfgang Holtmeier, Ute Körner, Dan A Leffler, Knut E A Lundin, Giuseppe Mazzarella, Chris J Mulder, Nicoletta Pellegrini, Kamran Rostami, David Sanders, Gry Irene Skodje, Detlef Schuppan, Reiner Ullrich, Umberto Volta, Marianne Williams, Victor F Zevallos, Yurdagül Zopf, Alessio Fasano, Carlo Catassi, Luca Elli, Bruno Bonaz, Gerd Bouma, Antonio Carroccio, Gemma Castillejo, Christophe Cellier, Fernanda Cristofori, Laura de Magistris, Jernej Dolinsek, Walburga Dieterich, Ruggiero Francavilla, Marios Hadjivassiliou, Wolfgang Holtmeier, Ute Körner, Dan A Leffler, Knut E A Lundin, Giuseppe Mazzarella, Chris J Mulder, Nicoletta Pellegrini, Kamran Rostami, David Sanders, Gry Irene Skodje, Detlef Schuppan, Reiner Ullrich, Umberto Volta, Marianne Williams, Victor F Zevallos, Yurdagül Zopf, Alessio Fasano

Abstract

Non-Celiac Gluten Sensitivity (NCGS) is a syndrome characterized by intestinal and extra-intestinal symptoms related to the ingestion of gluten-containing food, in subjects that are not affected by either celiac disease or wheat allergy. Given the lack of a NCGS biomarker, there is the need for standardizing the procedure leading to the diagnosis confirmation. In this paper we report experts' recommendations on how the diagnostic protocol should be performed for the confirmation of NCGS. A full diagnostic procedure should assess the clinical response to the gluten-free diet (GFD) and measure the effect of a gluten challenge after a period of treatment with the GFD. The clinical evaluation is performed using a self-administered instrument incorporating a modified version of the Gastrointestinal Symptom Rating Scale. The patient identifies one to three main symptoms that are quantitatively assessed using a Numerical Rating Scale with a score ranging from 1 to 10. The double-blind placebo-controlled gluten challenge (8 g/day) includes a one-week challenge followed by a one-week washout of strict GFD and by the crossover to the second one-week challenge. The vehicle should contain cooked, homogeneously distributed gluten. At least a variation of 30% of one to three main symptoms between the gluten and the placebo challenge should be detected to discriminate a positive from a negative result. The guidelines provided in this paper will help the clinician to reach a firm and positive diagnosis of NCGS and facilitate the comparisons of different studies, if adopted internationally.

Keywords: diagnosis; double-blind placebo-controlled challenge; gastrointestinal symptom rating scale; irritable bowel syndrome; non-celiac gluten sensitivity.

Figures

Figure 1
Figure 1
The numerical rating scale (NRS) used for rating the intensity of relevant items.
Figure 2
Figure 2
The flow diagram of the NCGS diagnostic process. GFD = gluten-free diet; A = product A (gluten or placebo); B = product B (placebo or gluten); E = evaluation (questionnaire). The evaluation is performed weekly during Step 1 and daily during Step 2.

References

    1. Sapone A., Lammers K.M., Mazzarella G., Mikhailenko I., Cartenì M., Casolaro V., Fasano A. Differential mucosal IL-17 expression in two gliadin-induced disorders: Gluten sensitivity and the autoimmune enteropathy celiac disease. Int. Arch. Allergy Immunol. 2010;152:75–80. doi: 10.1159/000260087.
    1. Biesiekierski J.R., Newnham E.D., Irving P.M., Barrett J.S., Haines M., Doecke J.D., Shepherd S.J., Muir J.G., Gibson P.R. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am. J. Gastroenterol. 2011;106:508–514. doi: 10.1038/ajg.2010.487.
    1. Junker Y., Zeissig S., Kim S.J., Barisani D., Wieser H., Leffler D.A., Zevallos V., Libermann T.A., Dillon S., Freitag T.L., et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. J. Exp. Med. 2012;209:2395–408. doi: 10.1084/jem.20102660.
    1. Volta U., Bardella M.T., Calabrò A., Troncone R., Corazza G.R. Study Group for Non-Celiac Gluten Sensitivity. An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Med. 2014;12 doi: 10.1186/1741-7015-12-85.
    1. Catassi C., Gatti S., Fasano A. The new epidemiology of celiac disease. J. Pediatr. Gastroenterol. Nutr. 2014;59:S7–S9. doi: 10.1097/01.mpg.0000450393.23156.59.
    1. Fasano A., Sapone A., Zevallos V., Schuppan D. Non-celiac Gluten Sensitivity. Gastroenterology. 2015;148:1195–1204. doi: 10.1053/j.gastro.2014.12.049.
    1. Carroccio A., Mansueto P., Iacono G., Soresi M., D’Alcamo A., Cavataio F., Brusca I., Florena A.M., Ambrosiano G., Seidita A., et al. Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity. Am. J. Gastroenterol. 2012;107:1898–1906. doi: 10.1038/ajg.2012.236.
    1. Biesiekierski J.R., Peters S.L., Newnham E.D., Rosella O., Muir J.G., Gibson P.R. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology. 2013;145:320–328. doi: 10.1053/j.gastro.2013.04.051.
    1. Czaja-Bulsa G. Non coeliac gluten sensitivity—A new disease with gluten intolerance. Clin. Nutr. 2014;34:189–194. doi: 10.1016/j.clnu.2014.08.012.
    1. Aziz I., Hadjivassiliou M. Coeliac disease: Noncoeliac gluten sensitivity—Food for thought. Nat. Rev. Gastroenterol. Hepatol. 2014;11:398–399. doi: 10.1038/nrgastro.2014.91.
    1. Jackson J., Eaton W., Cascella N., Fasano A., Santora D., Sullivan K., Feldman S., Raley H., McMahon R.P., Carpenter W.T., Jr., et al. Gluten sensitivity and relationship to psychiatric symptoms in people with schizophrenia. Schizophr. Res. 2014;159:539–542. doi: 10.1016/j.schres.2014.09.023.
    1. Catassi C., Bai J.C., Bonaz B., Bouma G., Calabrò A., Carroccio A., Castillejo G., Ciacci C., Cristofori F., Dolinsek J., et al. Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders. Nutrients. 2013;5:3839–3853. doi: 10.3390/nu5103839.
    1. Genuis S.J., Lobo R.A. Gluten sensitivity presenting as a neuropsychiatric disorder. Gastroenterol. Res. Pract. 2014;2014:293206. doi: 10.1155/2014/293206.
    1. Peters S.L., Biesiekierski J.R., Yelland G.W., Muir J.G., Gibson P.R. Randomised clinical trial: Gluten may cause depression in subjects with non-coeliac gluten sensitivity—An exploratory clinical study. Aliment. Pharmacol. Ther. 2014;39:1104–1112. doi: 10.1111/apt.12730.
    1. De Magistris L., Familiari V., Pascotto A., Sapone A., Frolli A., Iardino P., Carteni M., de Rosa M., Francavilla R., Riegler G., et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J. Pediatr. Gastroenterol. Nutr. 2010;51:418–424. doi: 10.1097/MPG.0b013e3181dcc4a5.
    1. Forsythe P., Bienenstock J., Kunze W.A. Vagal pathways for microbiome-brain-gut axis communication. Adv. Exp. Med. Biol. 2014;817:115–133.
    1. Glasziou P., Rose P., Heneghan C., Balla J. Diagnosis using “test of treatment”. BMJ. 2009;338 doi: 10.1136/bmj.b1312.
    1. Kulich K.R., Madisch A., Pacini F., Piqué J.M., Regula J., van Rensburg C.J., Ujszászy L., Carlsson J., Halling K., Wiklund I.K. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: A six-country study. Health Qual. Life Outcomes. 2008;6 doi: 10.1186/1477-7525-6-12.
    1. Sapone A., Bai J.C., Ciacci C., Dolinsek J., Green P.H., Hadjivassiliou M., Kaukinen K., Rostami K., Sanders D.S., Schumann M., et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 2012;10 doi: 10.1186/1741-7015-10-13.
    1. Van Overbeek F.M., Uil-Dieterman I.G., Mol I.W., Köhler-Brands L., Heymans H.S., Mulder C.J. The daily gluten intake in relatives of patients with coeliac disease compared with that of the general Dutch population. Eur. J. Gastroenterol. Hepatol. 1997;9:1097–1099. doi: 10.1097/00042737-199711000-00013.
    1. Caio G., Volta U., Tovoli F., De Giorgio R. Effect of gluten free diet on immune response to gliadin in patients with non-celiac gluten sensitivity. BMC Gastroenterol. 2014;14 doi: 10.1186/1471-230X-14-26.
    1. Navarro F., Pearson D.A., Fatheree N., Mansour R., Hashmi S.S., Rhoads J.M. Are “leaky gut” and behavior associated with gluten and dairy containing diet in children with autism spectrum disorders? Nutr. Neurosci. 2015;18:177–185. doi: 10.1179/1476830514Y.0000000110.
    1. Sapone A., Lammers K.M., Casolaro V., Cammarota M., Giuliano M.T., de Rosa M., Stefanile R., Mazzarella G., Tolone C., Russo M.I., et al. Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Med. 2011;9 doi: 10.1186/1741-7015-9-23.
    1. Hollon J., Puppa E.L., Greenwald B., Goldberg E., Guerrerio A., Fasano A. Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity. Nutrients. 2015;7:1565–1576. doi: 10.3390/nu7031565.
    1. Brottveit M., Beitnes A.C., Tollefsen S., Bratlie J.E., Jahnsen F.L., Johansen F.E., Sollid L.M., Lundin K.E. Mucosal cytokine response after short-term gluten challenge in celiac disease and non-celiac gluten sensitivity. Am. J. Gastroenterol. 2013;108:842–850. doi: 10.1038/ajg.2013.91.
    1. Cooper B.T., Holmes G.K., Ferguson R., Thompson R.A., Allan R.N., Cooke W.T. Gluten-sensitive diarrhea without evidence of celiac disease. Gastroenterology. 1980;79:801–806.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다